Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-13
DOI
10.3389/fimmu.2021.650708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- THE action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2020) Rodica Balasa et al. HUMAN IMMUNOLOGY
- Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE
- (2020) Zhan-Guo Li et al. ADVANCES IN THERAPY
- Controlled release of baricitinib from a thermos-responsive hydrogel system inhibits inflammation by suppressing JAK2/STAT3 pathway in acute spinal cord injury
- (2020) Xuan-Qi Zheng et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Involvement of the synapse-specific zinc transporter ZnT3 in cadmium-induced hippocampal neurotoxicity
- (2019) Safa Ben Mimouna et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effect of cornel iridoid glycoside on microglia activation through suppression of the JAK/STAT signalling pathway
- (2019) Zhao Qu et al. JOURNAL OF NEUROIMMUNOLOGY
- Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro
- (2019) Christina Gavegnano et al. Journal of Neuroinflammation
- Up-regulation of PGC-1α in neurons protects against experimental autoimmune encephalomyelitis
- (2019) Chun Dang et al. FASEB JOURNAL
- Baricitinib: A Review in Rheumatoid Arthritis
- (2018) Zaina T. Al-Salama et al. DRUGS
- Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats
- (2018) Cheng Chang et al. JOURNAL OF NEUROIMMUNOLOGY
- How much progress has there been in the second-line treatment of multiple sclerosis: A 2017 update
- (2018) A. Maarouf et al. REVUE NEUROLOGIQUE
- Oral Therapies for Multiple Sclerosis
- (2018) Simon Faissner et al. Cold Spring Harbor Perspectives in Medicine
- Efficacy of baricitinib in the treatment of rheumatoid arthritis
- (2017) Christophe Richez et al. EXPERT OPINION ON PHARMACOTHERAPY
- PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production
- (2017) Haijie Liu et al. FASEB JOURNAL
- MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by TargetingO-GlcNAc Transferase
- (2017) Ruiqiong Liu et al. JOURNAL OF IMMUNOLOGY
- Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
- (2017) Burhan Z. Chaudhry et al. Neurotherapeutics
- Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages
- (2017) Wei Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 (Programmed Death Ligand 1) Protects Against Experimental Intracerebral Hemorrhage–Induced Brain Injury
- (2017) Ranran Han et al. STROKE
- Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
- (2017) Bindee Kuriya et al. Therapeutic Advances in Musculoskeletal Disease
- Laquinimod in the treatment of relapsing remitting multiple sclerosis
- (2016) Undine Hainke et al. Expert Opinion on Drug Metabolism & Toxicology
- Age-dependent alterations to paraventricular nucleus insulin-like growth factor 1 receptor as a possible link between sympathoexcitation and inflammation
- (2016) Olalekan M. Ogundele et al. JOURNAL OF NEUROCHEMISTRY
- The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers
- (2014) Jack G. Shi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Loss of STAT3 in CD4 + T Cells Prevents Development of Experimental Autoimmune Diseases
- (2014) Xuebin Liu et al. JOURNAL OF IMMUNOLOGY
- Involvement of the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway in Multiple Sclerosis and the Animal Model of Experimental Autoimmune Encephalomyelitis
- (2014) Etty N. Benveniste et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- T helper cells plasticity in inflammation
- (2013) Lorenzo Cosmi et al. CYTOMETRY PART A
- Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of Experimental Autoimmune Encephalomyelitis
- (2013) Y. Liu et al. JOURNAL OF IMMUNOLOGY
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Amelioration of Experimental Autoimmune Encephalomyelitis by Plumbagin through Down-Regulation of JAK-STAT and NF-κB Signaling Pathways
- (2011) Yan Jia et al. PLoS One
- Differentiation of Effector CD4 T Cell Populations
- (2010) Jinfang Zhu et al. Annual Review of Immunology
- Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
- (2010) Amy E. Lovett-Racke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Regulation of Th1 and Th17 Cell Differentiation and Amelioration of Experimental Autoimmune Encephalomyelitis by Natural Product Compound Berberine
- (2010) X. Qin et al. JOURNAL OF IMMUNOLOGY
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
- Fingolimod is a potential novel therapy for multiple sclerosis
- (2010) Orhan Aktas et al. Nature Reviews Neurology
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Late Developmental Plasticity in the T Helper 17 Lineage
- (2009) Yun Kyung Lee et al. IMMUNITY
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Regulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation
- (2009) C. Chen et al. JOURNAL OF IMMUNOLOGY
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
- (2008) Chris J. Hedegaard et al. IMMUNOLOGY
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
- (2008) Dror Luger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterizing White Matter Damage in Rat Spinal Cord with Quantitative MRI and Histology
- (2008) Piotr Kozlowski et al. JOURNAL OF NEUROTRAUMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now